Nomura Holdings
DNA icon

Nomura Holdings’s Ginkgo Bioworks DNA Stock Holding History

Nomura Holdings’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-371
Closed -$26.8K – 1853
2023
Q3 		$26.8K Sell
371
-494
-57% -$39.5K ﹤0.01% 1310
2023
Q2 		$64.3K Sell
865
-1,670
-66% -$98.9K ﹤0.01% 1241
2023
Q1 		$135K Sell
2,535
-39
-2% -$2.47K ﹤0.01% 1264
2022
Q4 		$174K Buy
+2,574
New +$237K ﹤0.01% 1123
2021
Q4 		– Sell
-2,500
Closed -$1.15M – 2305
2021
Q3 		$1.15M Buy
+2,500
New +$1.22M 0.01% 1073

Other funds holding DNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return